Response of failing canine and human heart cells to beta 2-adrenergic stimulation. 1995

R A Altschuld, and R C Starling, and R L Hamlin, and G E Billman, and J Hensley, and L Castillo, and R H Fertel, and C M Hohl, and P M Robitaille, and L R Jones
Department of Medical Biochemistry, Ohio State University, Columbus 43210-1218, USA.

BACKGROUND Failing human hearts lose beta 1- but not beta 2-adrenergic receptors. In canine hearts with tachypacing failure, the ratio of beta 2- to beta 1-adrenergic receptors is increased. The present study was designed to determine whether heart failure increases sensitivity to beta 2-adrenergic stimulation in isolated canine ventricular cardiomyocytes and to verify that myocytes from failing human ventricles contain functional beta 2-adrenergic receptors. RESULTS Myocytes from healthy dogs, dogs with tachypacing failure, and human transplant recipients were loaded with fura 2-AM and subjected to electric field stimulation in the presence of zinterol, a highly selective beta 2-adrenergic agonist. Zinterol significantly increased [Ca2+]i transient amplitudes in all three groups. The failing canine myocytes were significantly more responsive than normal to beta 2-adrenergic stimulation. We also measured isotonic twitches, indo-1 fluorescence transients, and L-type Ca2+ currents in healthy canine myocytes. Zinterol (10(-5) mol/L) elicited large increases in the amplitudes of simultaneously recorded twitches and [Ca2+]i transients. Zinterol also increased L-type Ca2+ currents in the normal canine myocytes; this augmentation was abolished by 10(-7) mol/L ICI 118,551. cAMP production by suspensions of healthy and failing canine myocytes was not increased by zinterol (10(-9) to 10(-5) mol/L), nor did 10(-5) mol/L zinterol elicit phospholamban phosphorylation. CONCLUSIONS Failing human ventricular cardiomyocytes contain functional beta 2-adrenergic receptors. Canine myocytes also contain functional beta 2-adrenergic receptors. The canine ventricular response to beta 2-agonists is increased in tachypacing failure. Positive inotropic responses to beta 2-stimulation are not mediated by increases in cAMP or cAMP-dependent phosphorylation of phospholamban.

UI MeSH Term Description Entries
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D002135 Calcium-Binding Proteins Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS. Calcium Binding Protein,Calcium-Binding Protein,Calcium Binding Proteins,Binding Protein, Calcium,Binding Proteins, Calcium,Protein, Calcium Binding,Protein, Calcium-Binding
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004983 Ethanolamines AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives. Aminoethanols
D005260 Female Females
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts

Related Publications

R A Altschuld, and R C Starling, and R L Hamlin, and G E Billman, and J Hensley, and L Castillo, and R H Fertel, and C M Hohl, and P M Robitaille, and L R Jones
December 2009, Heart failure reviews,
R A Altschuld, and R C Starling, and R L Hamlin, and G E Billman, and J Hensley, and L Castillo, and R H Fertel, and C M Hohl, and P M Robitaille, and L R Jones
March 1989, Molecular pharmacology,
R A Altschuld, and R C Starling, and R L Hamlin, and G E Billman, and J Hensley, and L Castillo, and R H Fertel, and C M Hohl, and P M Robitaille, and L R Jones
December 1995, The Journal of clinical investigation,
R A Altschuld, and R C Starling, and R L Hamlin, and G E Billman, and J Hensley, and L Castillo, and R H Fertel, and C M Hohl, and P M Robitaille, and L R Jones
February 1993, Circulation,
R A Altschuld, and R C Starling, and R L Hamlin, and G E Billman, and J Hensley, and L Castillo, and R H Fertel, and C M Hohl, and P M Robitaille, and L R Jones
March 2007, Kardiologia polska,
R A Altschuld, and R C Starling, and R L Hamlin, and G E Billman, and J Hensley, and L Castillo, and R H Fertel, and C M Hohl, and P M Robitaille, and L R Jones
February 1994, Circulation research,
R A Altschuld, and R C Starling, and R L Hamlin, and G E Billman, and J Hensley, and L Castillo, and R H Fertel, and C M Hohl, and P M Robitaille, and L R Jones
January 2002, Cardiovascular research,
R A Altschuld, and R C Starling, and R L Hamlin, and G E Billman, and J Hensley, and L Castillo, and R H Fertel, and C M Hohl, and P M Robitaille, and L R Jones
January 1996, Basic research in cardiology,
R A Altschuld, and R C Starling, and R L Hamlin, and G E Billman, and J Hensley, and L Castillo, and R H Fertel, and C M Hohl, and P M Robitaille, and L R Jones
October 2012, The American journal of cardiology,
R A Altschuld, and R C Starling, and R L Hamlin, and G E Billman, and J Hensley, and L Castillo, and R H Fertel, and C M Hohl, and P M Robitaille, and L R Jones
April 2004, Circulation,
Copied contents to your clipboard!